<?xml version="1.0" encoding="UTF-8"?>
<ref id="B53" class="ref">
 <label class="label">53</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Sato</surname>
    <given-names class="given-names">M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Muragaki</surname>
    <given-names class="given-names">Y.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Saika</surname>
    <given-names class="given-names">S.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Roberts</surname>
    <given-names class="given-names">A. B.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Ooshima</surname>
    <given-names class="given-names">A.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Targeted disruption of TGF-
   <italic class="italic">Î²</italic>1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction
  </article-title>
  <source class="source">
   <italic class="italic">The Journal of Clinical Investigation</italic>
  </source>
  <year class="year">2003</year>
  <volume class="volume">112</volume>
  <issue class="issue">10</issue>
  <fpage class="fpage">1486</fpage>
  <lpage class="lpage">1494</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1172/JCI200319270</pub-id>
  <pub-id pub-id-type="other" class="pub-id">2-s2.0-0346727324</pub-id>
  <?supplied-pmid 14617750?>
  <pub-id pub-id-type="pmid" class="pub-id">14617750</pub-id>
 </element-citation>
</ref>
